These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 10520660)

  • 1. Non-alcoholic steatohepatitis.
    Krentz AJ
    Lancet; 1999 Oct; 354(9186):1300. PubMed ID: 10520660
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination therapy in type 2 diabetes: the role of repaglinide.
    Moses R
    J Assoc Physicians India; 2001 Jan; 49 Spec No():62-8. PubMed ID: 11235608
    [No Abstract]   [Full Text] [Related]  

  • 3. Severe cholestatic hepatitis from troglitazone in a patient with nonalcoholic steatohepatitis and diabetes mellitus.
    Menon KVN ; Angulo P; Lindor KD
    Am J Gastroenterol; 2001 May; 96(5):1631-4. PubMed ID: 11374713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes drug Rezulin: take it, but take precautions.
    Health News; 1999 May; 5(6):7. PubMed ID: 10546576
    [No Abstract]   [Full Text] [Related]  

  • 5. Substituting for troglitazone (Rezulin).
    Med Lett Drugs Ther; 2000 Apr; 42(1076):36. PubMed ID: 10803176
    [No Abstract]   [Full Text] [Related]  

  • 6. Rezulin to be withdrawn from the market.
    Diabetes Technol Ther; 2000; 2(2):289. PubMed ID: 11469272
    [No Abstract]   [Full Text] [Related]  

  • 7. Severe but reversible hepatitis induced by troglitazone.
    Schiano T; Dolehide K; Hart J; Baker AL
    Dig Dis Sci; 2000 May; 45(5):1039-42. PubMed ID: 10795774
    [No Abstract]   [Full Text] [Related]  

  • 8. Failure to develop hepatic injury from rosiglitazone in a patient with a history of troglitazone-induced hepatitis.
    Lenhard MJ; Funk WB
    Diabetes Care; 2001 Jan; 24(1):168-9. PubMed ID: 11194222
    [No Abstract]   [Full Text] [Related]  

  • 9. Oral hypoglycaemics. When not to use what.
    Phillips P; Braddon J
    Aust Fam Physician; 2002 Jul; 31(7):637-43. PubMed ID: 12143325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glitazones and NIDDM.
    Sakane N; Yoshida T; Kondo M
    Lancet; 1997 Mar; 349(9056):952. PubMed ID: 9093269
    [No Abstract]   [Full Text] [Related]  

  • 11. Avandia, a leading alternative for Rezulin patients, prescribed to more than 700,000 patients.
    Diabetes Technol Ther; 2000; 2(2):292. PubMed ID: 11469275
    [No Abstract]   [Full Text] [Related]  

  • 12. Warner-Lambert voluntarily withdraws Rezulin.
    Diabetes Technol Ther; 2000; 2(2):290. PubMed ID: 11469273
    [No Abstract]   [Full Text] [Related]  

  • 13. Troglitazone-associated hepatic failure.
    Booth AM; Caldwell SH; Iezzoni JC
    Am J Gastroenterol; 2000 Feb; 95(2):557-8. PubMed ID: 10685776
    [No Abstract]   [Full Text] [Related]  

  • 14. Pleuropulmonary disease in a man with diabetes who was treated with troglitazone.
    Koshida H; Shibata K; Kametani T
    N Engl J Med; 1998 Nov; 339(19):1400-1. PubMed ID: 9841315
    [No Abstract]   [Full Text] [Related]  

  • 15. Late-onset troglitazone-induced hepatic dysfunction.
    Bell DS; Ovalle F
    Diabetes Care; 2000 Jan; 23(1):128-9. PubMed ID: 10857986
    [No Abstract]   [Full Text] [Related]  

  • 16. Thiazolidinedione hepatotoxicity: a class effect?
    Tolman KG
    Int J Clin Pract Suppl; 2000 Oct; (113):29-34. PubMed ID: 11965828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Meta-analysis shows: insulin sensitizer is safe for the liver].
    MMW Fortschr Med; 2002 Oct; 144(40):47. PubMed ID: 12440297
    [No Abstract]   [Full Text] [Related]  

  • 18. Troglitazone for non-insulin-dependent diabetes mellitus.
    Med Lett Drugs Ther; 1997 May; 39(1001):49-51. PubMed ID: 9164446
    [No Abstract]   [Full Text] [Related]  

  • 19. A drug interaction between troglitazone and simvastatin.
    Lin JC; Ito MK
    Diabetes Care; 1999 Dec; 22(12):2104-6. PubMed ID: 10587866
    [No Abstract]   [Full Text] [Related]  

  • 20. A novel antidiabetic drug, troglitazone--reason for hope and concern.
    Imura H
    N Engl J Med; 1998 Mar; 338(13):908-9. PubMed ID: 9516229
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.